ADVOCATE HEALTH (FKA ADVOCATE AURORA HEALTH, INC.) for ADVOCATE HEALTH (FKA ADVOCATE AURORA HEALTH, INC.)
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Medicaid Funding; Health Care Innovation; Telehealth/Digital Health; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs; COVID-19
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANTHONY CURRY | — |
| JILL DOWELL - EFFECTIVE 2/9/21 New | — |
| THOMAS MCDANIELS New | — |
| JOYCE ROGERS | — |
Medicare/Medicaid MMM
340B Drug Pricing Program; Medicare Shared Savings Program; Medicare Advantage; Alternative Payment Models; Graduate Medical Education; Centers for Medicare and Medicaid Innovation; Stark Law Reform/Modernization; Value-Based Purchasing Payments; Post-Acute and Home Health Care Payments; Drug Pricing and Medicare Parts B and D; Medicare Regulatory Reform; Medicaid Funding; Health Care Innovation; Telehealth/Digital Health; S 433/HR 2753 Home Health Payment Innovation Act of 2019; S 296/HR 2150 Home Health Care Planning Improvement Act of 2019; Maternal Mortality; H.R. 1897/S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act); Surprise Billing; Anti-Kickback Reform; CREATES Act; HR 1499 Protecting Consumer Access to Generic Drugs; HR 987 Strengthening Health Care and Lowering Prescription Drug Costs; COVID-19
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANTHONY CURRY | — |
| JILL DOWELL - EFFECTIVE 2/9/21 | — |
| THOMAS MCDANIELS New | — |
| JOYCE ROGERS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.